Cholinergic urticaria are heat-related hives that cause raised, red spots or an itchy rash. They can occur anywhere on the body (though the neck and chest are common) and typically lead to itching.

In phase 3 trials, dupilumab significantly reduced itch and hives compared with placebo. The Food and Drug Administration (FDA) has approved Dupixent ® (dupilumab) for the treatment of adult and ...

Here's how to relieve the itching and get steps on preventing hives and avoiding your triggers. As small as jujubes or as large as saucers, hives are an allergic reaction that take the form of itchy ...

Are hives bugging you day and night? You don’t have to put up with the itch.

Sanofi SNY and partner Regeneron REGN announced that the FDA approved Dupixent (dupilumab) for the treatment of chronic spontaneous urticaria (“CSU”) in adults and adolescents aged 12 years ...

CSU can manifest differently on darker skin tones, making diagnosis and treatment more complex. Hives on Black skin may not present the typical redness seen on lighter skin; instead, they might appear ...

The U.S. FDA issued a complete response letter in October 2023 for Dupixent (dupilumab) in treating chronic hives but has now approved the monoclonal antibody for the indication. The approval makes ...

For the first time in Finland, researchers at the University of Jyväskylä’s Nanoscience Center have isolated a giant virus, which they have named Jyvaskylavirus. This discovery suggests that giant ...

Novartis is just months away from filing for approval of oral BTK inhibitor remibrutinib as a treatment for chronic spontaneous urticaria – also known as chronic hives – after reporting long ...